Escherichia coli O26 and O111 are classic enteropathogenic and emergent enterohemorrhagic E. coli (EHEC) serotypes. Among the 13 enteropathogenic serogroups, E. coli O26 and O111 are epidemiologically predominant and major causes of pediatric diarrhea, especially in developing countries (22, 29) . E. coli O111 caused 28% of the 50 U.S. infantile diarrhea outbreaks from 1934 to 1987 (33). Over the past 20 years, Shiga toxin-producing O26 and O111 emerged worldwide as the clinically most important non-O157 EHEC serotypes and were linked with sporadic cases and outbreaks of human disease, including hemorrhagic colitis and hemolytic-uremic syndrome (HUS) (8, 9, 28) . Several EHEC O26-and O111-caused outbreaks have occurred in Europe and Australia, and 25% of North American HUS cases may be attributable to non-O157 EHEC (13). In the United States, EHEC O111:NM caused a family cluster of diarrhea and HUS (3), and EHEC O111:H8 caused a gastroenteritis outbreak affecting more than 50 persons (1).
(ECRC 95.0122) whole-bacterium antigen. Immunization, hybridoma and ascites production, and MAb screening and characterization protocols were previously described (10, 11) . MAb were isotyped with a commercial kit (Zymed Laboratories, Inc., South San Francisco, Calif.). One anti-O26 MAb (12F5) and one anti-O111 MAb (15C4) were generated and characterized. MAb diagnostic sensitivity and specificity were estimated by enzyme-linked immunosorbent assay (ELISA) reactivity with whole-bacterium lysates from 400 gram-negative bacterial strains values for bacterial-antigen subsets were generated (Prism 3.0; Graph Pad Software Inc., San Diego, Calif.), and MAb diagnostic-sensitivity and -specificity point estimates with exact binomial 95% confidence intervals (CI) were calculated (Epi Info 6.0; Centers for Disease Control and Prevention, Atlanta, Ga.). Sensitivity was defined as the number of MAb ELISA-positive isolates per the total number of isolates tested possessing the target (O111 or O26) antigen. Specificity was defined as the number of MAb ELISA-nonreactive isolates per the total number of isolates tested that did not possess the target antigen.
MAb 12F5 (IgM isotype) reacted strongly by ELISA with 35 E. coli O26 isolates (sensitivity, 100%; 95% CI of 90.0 to 100) and cross-reacted with 1 of 369 non-E. coli O26 isolates (specificity, 99.73%; 95% CI of 98.5 to 99.99) (Fig. 1) . The crossreactive strain, E. coli O4:NM (CDC3377-85), was derived from a sporadic hemorrhagic-colitis case (32) and was subsequently retyped by the E. coli Reference Center (ECRC), Pennsylvania State University, University Park, as O negative: NM; the original O4 antigen was apparently lost on passage since its 1983 isolation. MAb 12F5 was later found to crossreact with bovine E. coli O-negative:NM field isolates (J. Keen, unpublished data). While the E. coli O26 O-antigen structure is known (20) , the nature of the MAb-defined O-antigen epitope common to E. coli O26 and E. coli O-negative:NM isolates is unknown. Importantly, MAb 12F5 did not react by ELISA with any bacteria that cross-react with anti-O26 PAb by agglutination.
MAb 15C4 (IgG3 isotype) reacted strongly by ELISA with 30 E. coli O111 strains (sensitivity, 100%; 95% CI of 88.4 to 100) and 8 Salmonella O35 isolates (Fig. 2) . MAb interaction with Salmonella O35 represents true antibody-antigen reactivity, not cross-reactivity, since the E. coli O111 and Salmonella O35 O antigens are identical (14) . MAb 15C4 did not react with 317 non-E. coli O111 or 49 Salmonella non-O35 isolates (specificity, 100%; 95% CI of 99.0 to 100).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (18), followed by Western immunoblotting (31) using semipurified LPS (17, 19) and whole-bacterium lysates from E. coli O26 and O111 and non-E. coli O26 and O111 as antigens, confirmed MAb O-antigen specificity. Reactive bands from gels transferred onto polyvinylidene difluoride membranes and incubated with MAb were revealed with HRP-conjugated rabbit anti-mouse IgGϩIgM and diaminobenzidine substrate (10). The ladder pattern characteristic of LPS was observed on silver-stained gels and MAb-incubated membranes (Fig. 3) . MAb 12F5 reacted with LPS from E. coli O26:H11 and O4:NM CDC3377-85 but not with LPS from five other bacterial strains. MAb 15C4 reacted only with E. coli O111 and Salmonella enterica serovar Adelaide O35 LPS. Similar immunoblots resulted when whole-bacterium lysates were used in place of LPS (data not shown).
In summary, we produced and characterized MAb against E. coli O26 and O111 that were sensitive and specific as assessed by ELISA against 400 target and nontarget isolates. Immunoblots against purified LPS confirmed MAb O-chain specificity. These MAb have potential use as immunodiagnostic reagents whether used alone or in combination with other phenotypic or genotypic markers.
